Pivalic acid-induced carnitine deficiency and physical exercise in humans

Metabolism: Clinical and Experimental
K AbrahamssonS Lindstedt

Abstract

To study the effect of carnitine depletion on physical working capacity, healthy subjects were administered pivaloyl-conjugated antibiotics for 54 days. The mean carnitine concentration in serum decreased from 35.0 to 3.5 mmicromol/L, and in muscle from 10 to 4.3 micromol/g noncollagen protein (NCP). Exercise tests were performed before and after 54 days' administration of the drug. At submaximal exercise, there was a slight increase in the concentration of 3-hydroxybutyrate in serum, presumably caused by decreased fatty acid oxidation in the liver. There was also a decreased consumption of muscle glycogen, indicating decreased glycolysis in the skeletal muscle. The muscle presumably had enough energy available, since there was no significant decrease in the concentration of adenosine triphosphate (ATP) and creatine phosphate during exercise. The work at maximal oxygen uptake (VO2max) and the maximal heart rate were reduced. Since VO2max is considered dependent on heart function, carnitine depletion seemed to affect cardiac function.

References

Jan 1, 1992·European Journal of Applied Physiology and Occupational Physiology·O J HeinonenM H Kvist
Sep 1, 1992·Scandinavian Journal of Clinical and Laboratory Investigation·E HolmeI Nordin
Jan 1, 1990·European Journal of Applied Physiology and Occupational Physiology·L VecchietN Siliprandi
Jan 1, 1990·European Journal of Applied Physiology and Occupational Physiology·V WyssA Rienzi
Aug 1, 1988·European Journal of Pediatrics·B O ErikssonI Nordin
Jan 1, 1987·European Journal of Applied Physiology and Occupational Physiology·C GreigC A Forte
Oct 15, 1987·Biochemical Pharmacology·B MeleghL L Bieber
Jun 1, 1985·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·S VickersB H Arison
Jan 1, 1985·European Journal of Applied Physiology and Occupational Physiology·C MarconiP Cerretelli
Mar 1, 1972·Clinica Chimica Acta; International Journal of Clinical Chemistry·G Cederblad, S Lindstedt
Oct 1, 1983·Physiological Reviews·J Bremer
Jan 1, 1984·Journal of Inherited Metabolic Disease·A G Engel, C J Rebouche
Dec 11, 1980·The New England Journal of Medicine·P R ChapoyS D Cederbaum
Jan 18, 1995·Biochimica Et Biophysica Acta·Q N DiepS Skrede
Jun 1, 1994·Biochemical Medicine and Metabolic Biology·K AbrahamssonI Nordin
Jun 1, 1994·Clinical Pharmacology and Therapeutics·E P BrassW R Hiatt

❮ Previous
Next ❯

Citations

Jan 13, 2011·The Journal of Antibiotics·Shunkichi TanakaHiroaki Shirahase
Dec 1, 1999·Nutrition Research Reviews·R J Maughan
Jun 3, 2016·Postgraduate Medical Journal·Arduino Arduini, Victor A Zammit

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.